loading
Precedente Chiudi:
$1.20
Aprire:
$1.25
Volume 24 ore:
137.68K
Relative Volume:
0.24
Capitalizzazione di mercato:
$41.18M
Reddito:
$1.05M
Utile/perdita netta:
$-48.82M
Rapporto P/E:
-0.7131
EPS:
-1.83
Flusso di cassa netto:
$-47.49M
1 W Prestazione:
+3.18%
1M Prestazione:
-16.12%
6M Prestazione:
-30.85%
1 anno Prestazione:
-81.87%
Intervallo 1D:
Value
$1.23
$1.32
Intervallo di 1 settimana:
Value
$1.165
$1.32
Portata 52W:
Value
$1.06
$10.24

Actinium Pharmaceuticals Inc Stock (ATNM) Company Profile

Name
Nome
Actinium Pharmaceuticals Inc
Name
Telefono
646-767-3870
Name
Indirizzo
275 Madison Avenue, 7th Floor, New York, NY
Name
Dipendente
25
Name
Cinguettio
@actiniumpharma
Name
Prossima data di guadagno
2025-03-14
Name
Ultimi documenti SEC
Name
ATNM's Discussions on Twitter

Confronta ATNM con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
ATNM
Actinium Pharmaceuticals Inc
1.305 41.18M 1.05M -48.82M -47.49M -1.83
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
490.08 127.47B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
577.44 62.43B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
599.32 37.03B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
232.66 31.06B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
249.34 26.16B 3.81B -644.79M -669.77M -6.24

Actinium Pharmaceuticals Inc Stock (ATNM) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-08-07 Downgrade B. Riley Securities Buy → Neutral
2024-05-14 Iniziato Stephens Overweight
2023-09-06 Iniziato HSBC Securities Buy
2023-02-21 Downgrade William Blair Outperform → Mkt Perform
2022-09-08 Iniziato Cantor Fitzgerald Overweight
2022-08-25 Iniziato B. Riley Securities Buy
2020-11-05 Iniziato Alliance Global Partners Buy
2017-12-06 Iniziato B. Riley FBR, Inc. Buy
2017-10-23 Ripresa ROTH Capital Buy
2017-09-14 Iniziato Maxim Group Buy
2016-08-25 Iniziato ROTH Capital Buy
2016-02-29 Iniziato H.C. Wainwright Buy
2015-10-15 Iniziato FBR Capital Outperform
2014-10-01 Iniziato MLV & Co Buy
2014-07-22 Iniziato Canaccord Genuity Buy
Mostra tutto

Actinium Pharmaceuticals Inc Borsa (ATNM) Ultime notizie

pulisher
05:46 AM

Levi & Korsinsky Reminds Actinium Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 27, 2025ATNM - marketscreener.com

05:46 AM
pulisher
Apr 21, 2025

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Solaris, Actinium, Bakkt, and Cerevel and Encourages Investors to Contact the Firm - GlobeNewswire Inc.

Apr 21, 2025
pulisher
Apr 21, 2025

Actinium Pharmaceuticals, Inc. Class Action: Levi & - GlobeNewswire

Apr 21, 2025
pulisher
Apr 21, 2025

Actinium Pharmaceuticals, Inc. Class Action: Levi & Korsinsky Reminds Actinium Investors of - Bluefield Daily Telegraph

Apr 21, 2025
pulisher
Apr 21, 2025

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Actinium Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming DeadlinesATNM - TradingView

Apr 21, 2025
pulisher
Apr 21, 2025

Class Action Filed Against Actinium Pharmaceuticals, Inc. (ATNM)May 27, 2025 Deadline to JoinContact The Gross Law Firm - PR Newswire

Apr 21, 2025
pulisher
Apr 20, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 20, 2025
pulisher
Apr 20, 2025

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Actinium - GlobeNewswire

Apr 20, 2025
pulisher
Apr 18, 2025

ATNM INVESTORS: Kirby McInerney LLP Reminds Actinium - GlobeNewswire

Apr 18, 2025
pulisher
Apr 18, 2025

ATNM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire

Apr 18, 2025
pulisher
Apr 18, 2025

ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Actinium Pharmaceuticals, Inc. Investors to Secure - Bluefield Daily Telegraph

Apr 18, 2025
pulisher
Apr 18, 2025

ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Actinium - GlobeNewswire

Apr 18, 2025
pulisher
Apr 18, 2025

ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Actinium Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ATNM - TradingView

Apr 18, 2025
pulisher
Apr 18, 2025

Actinium Pharmaceuticals, Inc. Sued for Securities Law - GlobeNewswire

Apr 18, 2025
pulisher
Apr 18, 2025

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of May 27, 2025 in Actinium Pharmaceuticals, Inc. LawsuitATNM - MarketScreener

Apr 18, 2025
pulisher
Apr 18, 2025

Actinium Pharmaceuticals (NYSE:ATNM) Stock Rating Upgraded by StockNews.com - Defense World

Apr 18, 2025
pulisher
Apr 17, 2025

The Gross Law Firm Reminds Actinium Pharmaceuticals, Inc. - GlobeNewswire

Apr 17, 2025
pulisher
Apr 17, 2025

ATNM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Actinium Pharmaceuticals, Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - markets.businessinsider.com

Apr 17, 2025
pulisher
Apr 17, 2025

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 27, 2025 in Actinium Pharmaceuticals, Inc. LawsuitATNM - PR Newswire

Apr 17, 2025
pulisher
Apr 16, 2025

ATNM Investors Have the Opportunity to Lead the Actinium Securities Fraud Lawsuit with Faruqi & Faruqi, LLP - GlobeNewswire

Apr 16, 2025
pulisher
Apr 16, 2025

Actinium Pharmaceuticals, Inc. Investors: Please contact - GlobeNewswire

Apr 16, 2025
pulisher
Apr 15, 2025

Kuehn Law Encourages Investors of Actinium Pharmaceuticals, Inc. to Contact Law Firm - The Malaysian Reserve

Apr 15, 2025
pulisher
Apr 15, 2025

ROSEN, A LEADING NATIONAL FIRM, Encourages Actinium Pharmaceuticals, Inc. Investors to Secure - Bluefield Daily Telegraph

Apr 15, 2025
pulisher
Apr 15, 2025

ROSEN, A LEADING NATIONAL FIRM, Encourages Actinium Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ATNM - TradingView

Apr 15, 2025
pulisher
Apr 15, 2025

Actinium Pharmaceuticals, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. May 27, 2025 Deadline to file Lead Plaintiff Motion - GlobeNewswire

Apr 15, 2025
pulisher
Apr 15, 2025

The Gross Law Firm Notifies Actinium Pharmaceuticals, Inc. - GlobeNewswire

Apr 15, 2025
pulisher
Apr 15, 2025

The Gross Law Firm Notifies Actinium Pharmaceuticals, Inc. Investors of a Class Action Lawsuit - Bluefield Daily Telegraph

Apr 15, 2025
pulisher
Apr 14, 2025

ATNM Investors are Reminded of the Class Action Against Actinium Pharmaceuticals, Inc.: Contact Robbins LLP for Information About How to Become Lead Plaintiff for the Class - PR Newswire

Apr 14, 2025
pulisher
Apr 13, 2025

ATNM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Actinium Pharmaceuticals, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! - markets.businessinsider.com

Apr 13, 2025
pulisher
Apr 13, 2025

Sei Investments Co. Invests $62,000 in Actinium Pharmaceuticals, Inc. (NYSE:ATNM) - Defense World

Apr 13, 2025
pulisher
Apr 12, 2025

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Actinium Pharmaceuticals, Inc. Investors to Secure - Bluefield Daily Telegraph

Apr 12, 2025
pulisher
Apr 12, 2025

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Actinium - GlobeNewswire

Apr 12, 2025
pulisher
Apr 12, 2025

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Actinium Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ATNM - TradingView

Apr 12, 2025
pulisher
Apr 12, 2025

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in - Bluefield Daily Telegraph

Apr 12, 2025
pulisher
Apr 11, 2025

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of May 27, 2025 in Actinium LawsuitATNM - PR Newswire

Apr 11, 2025
pulisher
Apr 10, 2025

ATNM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Actinium Pharmaceuticals, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit! - markets.businessinsider.com

Apr 10, 2025
pulisher
Apr 10, 2025

The Gross Law Firm Notifies Actinium Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineATNM - Morningstar

Apr 10, 2025
pulisher
Apr 09, 2025

Lawsuit filed for Investors who lost money with shares of Actinium Pharmaceuticals, Inc. (NYSE: ATNM) - openPR.com

Apr 09, 2025
pulisher
Apr 09, 2025

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Actinium Pharmaceuticals, Inc. Investors to - Bluefield Daily Telegraph

Apr 09, 2025
pulisher
Apr 09, 2025

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Actinium Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ATNM - TradingView

Apr 09, 2025
pulisher
Apr 09, 2025

ATNM LAWSUIT ALERT: Levi & Korsinsky Notifies Actinium Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ACCESS Newswire

Apr 09, 2025
pulisher
Apr 09, 2025

Levi & Korsinsky Notifies Actinium Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineATNM - ACCESS Newswire

Apr 09, 2025
pulisher
Apr 09, 2025

The Gross Law Firm Notifies Shareholders of Actinium Pharmaceuticals, Inc.(ATNM) of a Class - Bluefield Daily Telegraph

Apr 09, 2025
pulisher
Apr 09, 2025

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Actinium - GlobeNewswire

Apr 09, 2025
pulisher
Apr 09, 2025

ATNM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Actinium Pharmaceuticals, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! - markets.businessinsider.com

Apr 09, 2025
pulisher
Apr 08, 2025

ATNM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Actinium Pharmaceuticals, Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - markets.businessinsider.com

Apr 08, 2025
pulisher
Apr 08, 2025

Actinium Pharmaceuticals, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky Before May 27, 2025 to Discuss Your RightsATNM - PR Newswire

Apr 08, 2025
pulisher
Apr 08, 2025

Actinium Pharmaceuticals, Inc. (NYSE:ATNM) Receives $7.40 Consensus Target Price from Analysts - Defense World

Apr 08, 2025
pulisher
Apr 07, 2025

Shareholders of Actinium Pharmaceuticals, Inc. Should Contact Levi & Korsinsky Before May 27, 2025 to Discuss Your RightsATNM - ACCESS Newswire

Apr 07, 2025
pulisher
Apr 07, 2025

ATNM Stockholders Should Contact Robbins LLP for Information on How to Lead the Class Action Against Actinium Pharmaceuticals, Inc. - PR Newswire

Apr 07, 2025
pulisher
Apr 07, 2025

Shareholders that lost money on Actinium Pharmaceuticals, Inc.(ATNM) should contact The Gross Law Firm about pending Class ActionATNM - PR Newswire

Apr 07, 2025

Actinium Pharmaceuticals Inc Azioni (ATNM) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$19.80
price down icon 1.75%
$70.30
price up icon 2.22%
$32.51
price up icon 0.87%
$26.24
price up icon 1.84%
$102.53
price down icon 0.01%
biotechnology ONC
$248.35
price up icon 8.46%
Capitalizzazione:     |  Volume (24 ore):